EAHAD/LinkedIn
Aug 3, 2026, 12:44
Replaying the CSL Symposium on Gene Therapy Durability in Haemophilia – EAHAD
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Missed the CSL symposium on ‘Durability of gene therapy in haemophilia? Bridging trial results with clinical practice’ at EAHAD 2026?
The full session is now available on the EAHAD Academy.
Replay the session.
Free access”
Stay updated with Hemostasis Today.
-
Aug 3, 2026, 15:02David McIntosh: UK Plasma Action – a Founder’s Reflections
-
Aug 3, 2026, 14:49Ney Carter Borges: Targeting the Gut Microbiome to Prevent Atrial Fibrillation
-
Aug 3, 2026, 13:42Immune Thrombocytopenia: Moving Beyond Platelet Counts Toward Durable Remission
-
Aug 3, 2026, 13:28Aboo Shama Khan: Pulmonary Embolism – A Medical Emergency Every Nurse Must Recognize
-
Aug 3, 2026, 13:08Ashwin Patel: Evaluating Red Cell Function Post-Treatment in SCD Patients
-
Aug 3, 2026, 13:03Mohamed El Belghiti Alaoui: The Promise of AAV Gene Therapy in Hemophilia A
-
Aug 3, 2026, 12:43Shinta C: Takeda Marks a Milestone in Hemophilia Care
-
Aug 3, 2026, 12:37Deepak Kumar Dasmohapatra: Honored for Contributions to Transfusion Medicine and Immunohematology by the Governor of Chhattisgarh
-
Aug 3, 2026, 12:30Furkan Bahar: Thrombotic and Hemorrhagic Risk Profiles in Advanced Melanoma – Targeted vs Immune Combination Therapies